8Marit G. Treatment of relapsed or refractory acute leukencia: comparison of two different regimens[J]. Hematol and Blood Transfusion, 1990,33: 614.
9Broxterman H J, Sonneveld P, Pieters R, et al. Do Pglycoprotein and Majoy Vault Protein(MVP/TRP) expression correlate with in vitro daunornbicin resistame in acute myeloid leukemia? [J].Leukemia, 1999,13 (2): 258.
7Bandini G,Zuffa E,Rosti G,et al.Long-term outcome of adults with acute myelogenous leukemia:resules of a prospective,randomized study of chemotherapy with a minital follow-up of 7 years [J].Br J Haematol,1991,77(4):486-490.
8Bennett J M,Catovsky D,Daniel M T,et al.Prosed revised criteria for the classification of acute myeloid leukemia:a report of the French-American-British Cooperation Group[J].Ann Intern Med,1985,103(4):620-625.
9Brincker H,Christensen B E.Long-term survival and late relapses in acute leukemia in adults[J].Br J Harmatol,1990,74(2):156-160.
10Swansbury G T,Lawler S D,Alimena G,et al.Long-term survival in acute myelogenous leukemia:Asec ond follow-up of the Fourth International Workshop on chromosomes in leukemia[J].Cancer Genet Cytogenet,1994,73(1):1-7.
